GPT and metabolic dysfunction-associated steatotic liver disease: The mean ALT level was significantly higher in the NAFLD group (60.5 ± 11.8 U/L) compared to non-NAFLD individuals (38.4 ± 8.2 U/L) (p ≤ 0.001).